Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Agenus Inc (NASDAQ: AGEN) closed the day trading at $3.31 down -1.19% from the previous closing price of $3.35. In other words, the price has decreased by -$1.19 from its previous closing price. On the day, 0.73 million shares were traded. AGEN stock price reached its highest trading level at $3.36 during the session, while it also had its lowest trading level at $3.195.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 29 ’25 when Agenus Inc. bought 786,750 shares for $15.98 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AGEN now has a Market Capitalization of 112567632 and an Enterprise Value of 148524640. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.05. Its current Enterprise Value per Revenue stands at 1.39 whereas that against EBITDA is -2.954.
Stock Price History:
The Beta on a monthly basis for AGEN is 1.55, which has changed by 0.2304833 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, AGEN has reached a high of $7.34, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -17.50%, while the 200-Day Moving Average is calculated to be -17.49%.
Shares Statistics:
Over the past 3-months, AGEN traded about 516.94K shares per day on average, while over the past 10 days, AGEN traded about 750580 shares per day. A total of 32.81M shares are outstanding, with a floating share count of 32.35M. Insiders hold about 4.88% of the company’s shares, while institutions hold 22.94% stake in the company. Shares short for AGEN as of 1765756800 were 2774043 with a Short Ratio of 5.37, compared to 1763078400 on 1789317. Therefore, it implies a Short% of Shares Outstanding of 2774043 and a Short% of Float of 8.229999000000001.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $1.8, with high estimates of $1.8 and low estimates of $1.8.
Analysts are recommending an EPS of between -$3.85 and -$3.85 for the fiscal current year, implying an average EPS of -$3.85. EPS for the following year is $1.96, with 2.0 analysts recommending between $3.41 and $0.5.
Revenue Estimates
3 analysts predict $53.1M in revenue for. The current quarter. It ranges from a high estimate of $105.2M to a low estimate of $26.09M. As of. The current estimate, Agenus Inc’s year-ago sales were $26.84MFor the next quarter, 3 analysts are estimating revenue of $65.8M. There is a high estimate of $101.4M for the next quarter, whereas the lowest estimate is $30.2M.
A total of 3 analysts have provided revenue estimates for AGEN’s current fiscal year. The highest revenue estimate was $185.2M, while the lowest revenue estimate was $106.08M, resulting in an average revenue estimate of $133.09M. In the same quarter a year ago, actual revenue was $103.46MBased on 3 analysts’ estimates, the company’s revenue will be $154.52M in the next fiscal year. The high estimate is $232M and the low estimate is $110.67M.
